959 related articles for article (PubMed ID: 15494706)
1. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
Van Gool AR; Verkerk R; Fekkes D; Bannink M; Sleijfer S; Kruit WH; van der Holt B; Scharpé S; Eggermont AM; Stoter G; Hengeveld MW
Psychiatry Clin Neurosci; 2008 Oct; 62(5):597-602. PubMed ID: 18950381
[TBL] [Abstract][Full Text] [Related]
3. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
4. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
5. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
6. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients.
Huttunen R; Syrjänen J; Aittoniemi J; Oja SS; Raitala A; Laine J; Pertovaara M; Vuento R; Huhtala H; Hurme M
Shock; 2010 Feb; 33(2):149-54. PubMed ID: 19487973
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
[TBL] [Abstract][Full Text] [Related]
8. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
9. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
10. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.
Wichers MC; Maes M
J Psychiatry Neurosci; 2004 Jan; 29(1):11-7. PubMed ID: 14719046
[TBL] [Abstract][Full Text] [Related]
11. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D
Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303
[TBL] [Abstract][Full Text] [Related]
13. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
14. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
15. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.
Murakami Y; Ishibashi T; Tomita E; Imamura Y; Tashiro T; Watcharanurak K; Nishikawa M; Takahashi Y; Takakura Y; Mitani S; Fujigaki H; Ohta Y; Kubo H; Mamiya T; Nabeshima T; Kim HC; Yamamoto Y; Saito K
Sci Rep; 2016 Jul; 6():29920. PubMed ID: 27436416
[TBL] [Abstract][Full Text] [Related]
16. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
18. A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection.
Baranyi A; Meinitzer A; Stepan A; Putz-Bankuti C; Breitenecker RJ; Stauber R; Kapfhammer HP; Rothenhäusler HB
Psychother Psychosom; 2013; 82(5):332-40. PubMed ID: 23942342
[TBL] [Abstract][Full Text] [Related]
19. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
Sakurai K; Matsuo S; Enomoto K; Tani M; Kitajima A; Amano S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
[TBL] [Abstract][Full Text] [Related]
20. Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals.
Raitala A; Pertovaara M; Karjalainen J; Oja SS; Hurme M
Scand J Immunol; 2005 Apr; 61(4):387-90. PubMed ID: 15853924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]